G’day Great Lakes NeuroTechnologies

Valley View-based Great Lakes NeuroTechnologies have received TGA approval to market their Kinesia technology in Australia. The product line  includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated with Parkinson’s disease and in response to treatments.

Market applications include both in-clinic and home-based telemedicine patient care, assistance in programming deep brain stimulation, and providing quantitative endpoints to determine efficacy in clinical trials.

 

“Achieving TGA certification to market in Australia represents our commitment to delivering innovative, high quality medical technology and increasing our growth in international markets,” said Dave Tucholski, director of Quality and Regulatory Affairs. “This expands upon our previous regulatory successes including FDA clearance, CE Mark, and ISO certification.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

CareSource to set up new office in Indianapolis | Dayton Business Journal, September 30, 2014

CoverMyMeds receives a six-year, 40 percent tax credit expected to create more than 100 jobs | Columbus Business First, September 29, 2014

Ohio Community Colleges receive $25M in funding to provide job training skills | Cleveland.com, September 29, 2014

NanoLogix news: Tech cited in World Health Organization UNITAID annual report on TB and The Ohio State University issues purchase order for lab supplies (pdf) | NanoLogix, September 29, 2014

Ohio Clinical Trials Collaborative launches in European market | Business Wire, September 29, 2014

$1M anonymous gift allows Northern Kentucky University to invest in Cintrifuse | River City News, September 28, 2014

Ohio State University and Air Force researchers to collaborate on neurological study | Columbus Dispatch, September 26, 2014

BioMotiv attracts $25M Japanese pharmaceutical giant Takeda | Cleveland.com, September 25, 2014

BioMotiv and Takeda Pharmaceutical Company enter into strategic partnership | BioMotiv, September 25, 2014

TechColumbus First Connect program links entrepreneurs with big customers | Columbus CEO, September 24, 2014

Explorys wins NorTech Innovation Award for Most Innovative Use of a National Trend for Big Data | Explorys, September 24, 2014

Medpace salutes Julie J. Hopkins, Cincinnati Leukemia & Lymphoma Society Woman of the Year 2014 (pdf) | Medpace, September 23, 2014

University of Cincinnati, Cincinnati Children’s doctor develops innovative food allergy shot | Cincinnati Business Courier, September 23, 2014

Cincinnati Children’s Hospital Medical Center receives $3.5M Healthy Start grant to fight infant mortality | WCPO9 Cincinnati, September 23, 2014

Cleveland Clinic to open Center for Functional Medicine led by Dr. Mark Hyman | Cleveland.com, September 22, 2014

New stem cell procedure performed at The Ohio Stem Cell Treatment Center in Beachwood could help some avoid surgery | Newsnet5 Cleveland, September 22, 2014

New anti-cancer peptide vaccines and inhibitors developed by Ohio State University researchers | OSU Comprehensive Cancer Center, September 22, 2014

AtriCure announces the release of the AtriClip FLEX | AtriCure, September 18, 2014

Minimally Invasive Devices launches FloShield Air | PR Newswire, September 18, 2014

Boehringer Ingelheim joins local partners to support Drug Disposal Day October 11th | WCMH-NBC4, September 18, 2014